February 05, 2026

Oral TYK2 Inhibition in Atopic Dermatitis

Phase 2 trial evaluated once-daily oral TYK2 inhibition in adults with moderate to severe AD.

Conexiant

February 04, 2026

Who Decides When a Doctor Steps Back?

Cognitive decline, credentialing, and why “I’ll know” often isn’t enough.

KFF Health News

January 27, 2026

The Exam Room Is Listening Now

As AI quietly enters exam rooms, physicians report real relief—and real concerns about accuracy, trust, and control.

KFF Health News

January 23, 2026

US Leaves WHO Over Pandemic, Governance

The announcement describes a shift toward direct engagement with countries and organizations outside the World Health Organization.

Conexiant

January 20, 2026

IVF Babies and Allergy Risk: New Data

Cohort study of nearly 70,000 patients finds modest but statistically significant associations between assisted reproduction and asthma, allergic rhinitis, and atopic dermatitis

Conexiant

January 08, 2026

Rapid Itch Relief Seen with Nemolizumab

Researchers examined early itch and sleep outcomes with interleukin-31 pathway inhibition in atopic dermatitis and prurigo nodularis in phase 3 trial analyses.

Conexiant

September 19, 2025

Vaccine Playbook Rewrite: Who’s In Charge?

HHS Secretary Robert F. Kennedy Jr.’s changes at the CDC are prompting states and medical societies to issue independent vaccine recommendations, challenging long-standing national immunization policy.

KFF Health News

November 01, 2024

Are Antibiotics Needed for Pediatric Pneumonia?

Nearly one in five children diagnosed with pneumonia in outpatient settings did not receive antibiotics, according to a recent study in JAMA Network Open.

Conexiant

January 06, 2025

Does JIA Increase Arthritis Risk?

Explore how genetic overlap links juvenile idiopathic arthritis to adult rheumatic diseases.

Conexiant